Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market

Market Synopsys

The global Infectious Disease Diagnostics Market is valued at USD 23.1 Billion in 2024 and is projected to reach a value of USD 54.35 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.10% between 2025 and 2035. The epidemiological weight of infectious diseases like extreme intense respiratory condition (SARS), Middle East respiratory disorder (MERS), Ebola, chikungunya, avian influenza, pig influenza, and Zika has opened entryway for their initial conclusion and avoidance. Essentially, current episode of COVID-19 pandemic has enormously expanded the interest for different POC analytic packs for early analysis and control the spread of COVID. Further, the developing mindfulness for early location utilizing explicit symptomatic tests, development in subsidizing for research on irresistible illness diagnostics, and change in center from concentrated labs to decentralized reason behind care testing administrations are relied upon to impel the development of the worldwide irresistible sickness diagnostics market. Nonetheless, negative and deficient repayment situation is relied upon to hamper the development of the irresistible illness diagnostics market.

Diagnostics assume an imperative part in deciding the bearing of any clinical treatment. While irresistible sicknesses diagnostics help in diagnosing illnesses caused because of pathogenic disease. The world of diagnostics is developing quickly and the global market for Infectious Disease Diagnostics is developing at a consistent speed in the next upcoming years.

Market Segmentation:

The global Infectious Disease Diagnostics market is segmented on the basis of product, type of testing, technology, disease type and end use. Based on product, the market is segmented as reagents, kits & consumables; instruments; and software & services. By type, the market is segmented into laboratory testing and POC testing. By technology, the market is segmented into immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarrays, other technologies. By disease type, the market is segmented into Covid-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, other infectious diseases. By end user, the market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users.

Based on product, reagents, kits, and consumables segment holds a major revenue share in the Infectious Disease Diagnostics market

In 2024, the reagents, kits and consumables segment holds a major revenue share in the target market. Increasing demand and purchase of these products owing to their frequent use augments the growth of this segment.

Based on type of testing, POC testing segment grows at a rapid pace in the Infectious Disease Diagnostics market over the forecast period

The POC testing segments is projected to grow at a rapid CAGR in the target market over the forecast period, owing to increasing prevalence of infectious diseases.

Based on technology, immunodiagnostics accounted a major share in the market

In 2024, the immunodiagnostics segment is expected to hold for a major share in terms of revenue in the target market. This can be attributed to the increased use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend in automation.

{{segment_3_graph}}

Based on diseases type, the hepatitis holds the largest share of the global Infectious Disease Diagnostics market

The hepatitis sicknesses fragment is assessed to hold the biggest portion of the global Infectious Disease Diagnostics market in 2024. Expanding number of blood bonding and gifts, expanding commonness of hepatitis B and C contaminations, rising vulnerability of the geriatric populace, developing mindfulness among the populace, and advantages presented by point of care instruments and units are relied upon to push the development of this section.

{{segment_4_graph}}

Based on end user, hospitals & clinics segment accounts for largest revenue share in the Infectious Disease Diagnostics market over the forecast period

The hospitals & clinics segments is expected to account for largest revenue share in the target market over the forecast period, owing to increasing number of infectious diseases.

{{segment_5_graph}}

In the region, the Asia Pacific Infectious Disease Diagnostics market holds significant revenue share

North America Infectious Disease Diagnostics market is expected to hold significant revenue share in terms of revenue, whereas, Asia Pacific market is projected to grow at a rapid CAGR during the forecast period. The variables driving the growth of the Infectious Disease Diagnostics market in Asia Pacific are rapid urbanization, expanding speculation by healthcare providers for infrastructure improvement, the need to treat infectious diseases, and government efforts to further develop the availability of symptomatic management through the creation of programs or detection of infectious diseases at an early stage.

Competitive Landscape

The key players in the Infectious Disease Diagnostics market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), bioMérieux SA (France), Danaher Corporation (US), Hologic, Inc. (US), Quidel Corporation (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Ortho Clinical Diagnostics (US), Sysmex Corporation (Japan), Luminex Corporation (US), Genetic Signatures (Australia), Meridian Bioscience (US), OraSure Technologies (US), Chembio Diagnostic Systems, Inc. (US), Trinity Biotech Plc. (Ireland), Seegene Inc. (South Korea), ELITechGroup (France), Co-Diagnostics, Inc. (US), Epitope Diagnostics, Inc. (US), Meril Life Sciences Pvt. Ltd. (India), Trivitron Healthcare (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).

Infectious Disease Diagnostics Market is Segmented as Follows:

Infectious Disease Diagnostics Market is Tabulated as Follows: